You are here: Industry Insights > Innovus Pharmaceuticals

News List

Aytu BioScience and Innovus Pharmaceuticals Announce Filing of Form S-4 Registration Statement Related to Proposed Acquisition of Innovus by Aytu BioScience firstwordpharm
December 25, 2019
The registration statement containing the joint preliminary proxy statement/prospectus is available through the SEC's website at www.sec.gov and on each company's website on the respective company's Investor section.
Innovus Pharma announces $3.17 million private placement biospectrumasia
January 02, 2019
The net proceeds from the offering are anticipated to be approximately $2.765 million. The Company intends to use the net proceeds for working capital and general corporate purposes.
Innovus Pharmaceuticals Acquires Worldwide Rights to Four Products from Boston Topicals, LLC pharmafocusasia
November 26, 2018
We continue to bolster our product pipeline with clinically and commercially validated products that fit both our direct to consumer channels as well as retail....